GDTC

CytoMed Therapeutics Limited Ordinary Shares (GDTC)

Stock · NASDAQ · Health Care

$0.92as of 8/28/2026

Active signals

Resistance level
$0.996075
Industry
Biotechnology: Pharmaceutical Preparations

About GDTC

Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations

Fundamentals

Market cap
$9.50M
P/E (trailing)
P/E (forward)
EPS (trailing)
$-0.34
Dividend yield
Beta
0.02
Avg. volume
52-week range
$0.6801$3.68

CytoMed Therapeutics Limited Ordinary Shares Competitors

Chosen by industry and closest market cap.

  • GDTC
    CytoMed Therapeutics Limited Ordinary Shares
    $0.92
    ▼ 4.17%
    Market cap $9.50MP/E
    $0.6801$3.68
  • QNRX
    Quoin Pharmaceuticals Ltd. American Depositary Shares
    $6.13
    ▲ 18.91%
    Market cap $9.18MP/E
    $3.25$41.8
  • LEXX
    Lexaria Bioscience Corp. Common Stock
    $10.35
    ▼ 11.39%
    Market cap $8.82MP/E
    $4.21$23.25
  • ADIL
    Adial Pharmaceuticals Inc Common Stock
    $5.6
    ▼ 1.41%
    Market cap $10.29MP/E
    $1.31$249.81
  • TOVX
    Theriva Biologics Inc. Common Stock
    $0.247
    ▼ 1.20%
    Market cap $10.32MP/E
    $0.1628$0.8632
  • XCUR
    Exicure Inc. Common Stock
    $1.34
    ▼ 5.32%
    Market cap $8.60MP/E
    $1.05$9.48
  • SNGX
    Soligenix Inc. Common Stock
    $0.38
    ▲ 0.00%
    Market cap $8.24MP/E
    $0.28$3.22

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions
Acquired
312.0K
Disposed
0

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.